Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

58.15
BATS BZX Real-Time Price
As of 3:24pm ET
 +1.94 / +3.44%
Today’s Change
27.14
Today|||52-Week Range
80.71
-26.75%
Year-to-Date
US Prisons Experiment With Addiction Treatment for Inmates
Nov 29 / GuruFocus News - Paid Partner Content
Acorda Stops Post-Stroke Development Program on Ampyra
Nov 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close56.21
Today’s open56.28
Day’s range56.11 - 58.17
Volume24,715
Average volume (3 months)1,076,710
Market cap$8.5B
Dividend yield--
Data as of 3:24pm ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)-623.81%
Earnings growth (this year)+34.92%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+1.54%
P/E ratioNM
Price/Sales18.85
Price/Book6.45

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-0.26-0.56%
SGENSeattle Genetics Inc+0.36+0.54%
TSROTESARO Inc+0.78+0.56%
JAZZJazz Pharmaceuticals...+2.17+2.14%
Data as of 3:25pm ET, 12/06/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$628.3M
Annual profit (last year)-$227.2M
Net profit margin-36.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs